Context Therapeutics Inc. (CNTX)
NASDAQ: CNTX · Real-Time Price · USD
1.090
-0.040 (-3.54%)
At close: Oct 31, 2025, 4:00 PM EDT
1.130
+0.040 (3.67%)
After-hours: Oct 31, 2025, 7:38 PM EDT
Context Therapeutics Market Cap
Context Therapeutics has a market cap or net worth of $97.78 million as of October 31, 2025. Its market cap has decreased by -36.40% in one year.
Market Cap
97.78M
Enterprise Value
14.43M
1-Year Change
-36.40%
Ranking
Category
Stock Price
$1.09
Market Cap Chart
Since the IPO on October 20, 2021, Context Therapeutics's market cap has increased from $51.03M to $97.78M, an increase of 91.62%. That is a compound annual growth rate of 17.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 31, 2025 | 97.78M | 3.81% |
| Dec 31, 2024 | 94.19M | 422.07% |
| Dec 29, 2023 | 18.04M | 73.39% |
| Dec 30, 2022 | 10.41M | -75.50% |
| Dec 31, 2021 | 42.46M | -16.78% |
| Oct 20, 2021 | 51.03M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 766.99B |
| Johnson & Johnson | 452.66B |
| AbbVie | 383.61B |
| UnitedHealth Group | 308.37B |
| AstraZeneca | 255.76B |
| Novartis AG | 236.67B |
| Novo Nordisk | 222.08B |
| Abbott Laboratories | 215.17B |